Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells.
about
Epigenetic Changes in Endothelial Progenitors as a Possible Cellular Basis for Glycemic Memory in Diabetic Vascular ComplicationsTGF-beta1-induced plasminogen activator inhibitor-1 expression in vascular smooth muscle cells requires pp60(c-src)/EGFR(Y845) and Rho/ROCK signaling.Rho-kinase inhibition acutely augments blood flow in focal cerebral ischemia via endothelial mechanismsHyperglycemia modulates plasminogen activator inhibitor-1 expression and aortic diameter in experimental aortic aneurysm disease.Increased leukocyte rho kinase (ROCK) activity and endothelial dysfunction in cigarette smokersSulforaphane inhibits TNF-α-induced adhesion molecule expression through the Rho A/ROCK/NF-κB signaling pathway.Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis.RhoA/Rho-kinase and vascular diseases: what is the link?Involvement of RhoA/ROCK1 signaling pathway in hyperglycemia-induced microvascular endothelial dysfunction in diabetic retinopathyEmerging roles of the myocardin family of proteins in lipid and glucose metabolism.Rho-associated coiled-coil-forming kinases (ROCKs): potential targets for the treatment of atherosclerosis and vascular disease.Metabolic factors, adipose tissue, and plasminogen activator inhibitor-1 levels in type 2 diabetes: findings from the look AHEAD studyRho kinase as a therapeutic target in cardiovascular disease.The Cell Adhesion Molecule Necl-4/CADM4 Serves as a Novel Regulator for Contact Inhibition of Cell Movement and Proliferation.Role of Rho kinase isoforms in murine allergic airway responses.Involvement of Rho-associated protein kinase (ROCK) and bone morphogenetic protein-binding endothelial cell precursor-derived regulator (BMPER) in high glucose-increased alkaline phosphatase expression and activity in human coronary artery smooth muGender difference in rat aorta vasodilation after acute exposure to high glucose: involvement of protein kinase C beta and superoxide but not of Rho kinase.Effects and mechanism of moderate aerobic exercise on impaired fasting glucose improvementPhysiological role of ROCKs in the cardiovascular systemROCK1 mediates leukocyte recruitment and neointima formation following vascular injuryFHL2 prevents cardiac hypertrophy in mice with cardiac-specific deletion of ROCK2.Prevention of diabetes-induced arginase activation and vascular dysfunction by Rho kinase (ROCK) knockout.Atherosclerosis in diabetes and insulin resistance.Rho kinase (ROCK) inhibitors.Does it matter whether or not a lipid-lowering agent inhibits Rho kinase?Critical role of sphingosine-1-phosphate receptor 2 (S1PR2) in acute vascular inflammation.Increased Rho kinase activity in a Taiwanese population with metabolic syndrome.Rho kinase inhibition improves endothelial function in human subjects with coronary artery disease.Comparison of effects of rosuvastatin (10 mg) versus atorvastatin (40 mg) on rho kinase activity in caucasian men with a previous atherosclerotic event.Statins inhibit Rho kinase activity in patients with atherosclerosis.Rho-associated kinase activity, endothelial function, and cardiovascular risk factors.The pericyte: cellular regulator of microvascular blood flowRho kinases in cardiovascular physiology and pathophysiology: the effect of fasudil.Revisited and revised: is RhoA always a villain in cardiac pathophysiology?Long-term diabetic complications may be ameliorated by targeting Rho kinase.Endothelial dysfunction and hypertension in aging.RhoA/mDia-1/profilin-1 signaling targets microvascular endothelial dysfunction in diabetic retinopathy.PKC-β exacerbates in vitro brain barrier damage in hyperglycemic settings via regulation of RhoA/Rho-kinase/MLC2 pathwayEffects of systemic inhibition of Rho kinase on blood pressure and renal haemodynamics in diabetic rats.N-acetylcysteine attenuates systemic platelet activation and cerebral vessel thrombosis in diabetes.
P2860
Q26859263-8139326A-61D0-43DE-9CE9-D7AD35FEFF88Q30440157-01611A0E-3326-428A-A9E1-68EAA3980308Q33260026-A0120EA3-5CF5-4F46-8BE1-D6043FE78D98Q34001108-0870DC4B-4155-41E9-B418-3D914B0A65FEQ34088790-18BD439B-4653-4FCB-B954-1C0C360ECA76Q34290991-7E75F042-9904-453C-865E-66BE7879C920Q34362144-A68DAD57-04F4-452C-A230-1F2292F41273Q34378293-F4BCCBBC-4899-40D8-B3A7-A5DB5EED1F83Q34501845-0B49A8FE-1A1D-4366-AD5B-23869E7F96ACQ34521411-2300F971-4620-46DA-8990-A09DDBBE94CCQ34823543-72FCDF74-E901-44DF-9A65-BF1BEFB8B0CDQ35088730-DF476FA5-DFCC-4D9F-BC65-C54E038EBA0BQ35352722-58399056-40E0-4D40-B3F8-E2F3952FBF39Q35609836-C857390E-1CF6-4E1F-B00D-DC2D5417D86AQ35687203-D289F779-7A54-4EC6-B156-E6CE0055EEF7Q35945951-A3A79EC9-0BF0-432B-AA18-DF090B7C308BQ36248761-BDE4E0F6-B1AE-44A0-A9A5-48CD43CB96A9Q36344151-DC4E950E-5666-4197-9E35-CE6B484C5376Q36392528-EC5629B2-4E87-41AE-B758-8DE674EF83C2Q36540884-F6A24895-F136-4AA6-84E2-C4F5CBF1AADCQ36710880-9D2920D6-B96F-4BD7-BCD4-772C91BA4FDBQ36787307-5DBE871E-C910-4542-AFDA-0664667C6DB5Q36857541-953C369B-9649-4003-92A3-97E02BAF5F26Q36897945-E382E80E-7842-4F34-A2A8-817E05954913Q37000895-F96F16BF-E673-4519-A5DD-7732BCA77375Q37026776-27E779F2-10EF-4126-A2E9-ED18BAE83FF5Q37041722-2335FA64-1B89-4B14-887B-9C0EDFA9C598Q37151565-F024F36C-DFC4-415F-901F-A099C0464A9DQ37170931-A0327574-4821-471C-B913-07B3EE8271E6Q37279038-628008B0-1354-4456-819D-BBEC07664987Q37367339-68149F8C-2562-4C6C-A344-B629169FBEFBQ37424313-0D485D68-0BAE-4A10-BA33-55B152522B85Q37450106-047D5687-0E07-4BAC-927D-453DD7F3331EQ37766125-9328DAFC-9A02-405E-AEE1-F7E7EFE23346Q37838899-189A64AA-9F69-4926-B3AC-53AF737608CCQ38042870-3FE2EC64-65B4-4149-9E55-56DA66FFA458Q38384340-42F568F9-C028-45D6-BF4B-38E83FB0EEECQ39107503-DCA15116-556C-451C-9389-B0CB625E38C8Q41539692-5481FF5A-F195-4178-882A-9A7938DF4491Q41927946-A1F1A55E-2F52-4F3C-973A-5D737041FA88
P2860
Rho-kinase mediates hyperglycemia-induced plasminogen activator inhibitor-1 expression in vascular endothelial cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 13 June 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Rho-kinase mediates hyperglyce ...... in vascular endothelial cells.
@en
Rho-kinase mediates hyperglyce ...... in vascular endothelial cells.
@nl
type
label
Rho-kinase mediates hyperglyce ...... in vascular endothelial cells.
@en
Rho-kinase mediates hyperglyce ...... in vascular endothelial cells.
@nl
prefLabel
Rho-kinase mediates hyperglyce ...... in vascular endothelial cells.
@en
Rho-kinase mediates hyperglyce ...... in vascular endothelial cells.
@nl
P2860
P1433
P1476
Rho-kinase mediates hyperglyce ...... in vascular endothelial cells.
@en
P2093
James K Liao
Yoshiyuki Rikitake
P2860
P304
P356
10.1161/CIRCULATIONAHA.105.534024
P407
P577
2005-06-13T00:00:00Z